Utah Medical Products, Inc.

UTMD Healthcare Medical Instruments & Supplies

Utah Medical Products, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.5 million, down 5.83% from fiscal 2024. In the quarter to June 2026, revenue fell 14.3%, EPS fell 10.6% and free cash flow fell 55.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years.

74.51 0.41 −0.55%
Market cap
$237.8M
P/E
22.7×
Fwd P/E
28.7×
Dividend yield
1.66%
F-score
6/9
Altman Z
36.25
Beneish M
−2.68
Dividend safety
82/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

6 6 6 7
ROE
9.59% 9.54% 9.14% 8.75%
ROA
9.24% 9.21% 8.79% 8.55%
ROIC
21.87% 21.26% 20.50% 18.60%
Return on Tangible Assets
11.23% 10.74% 10.18% 9.69%
Average Days of Receivables
35.19 33.37 35.36 36.04
Free Cash Flow per Share
4.33 4.42 4.09 3.60
Free Cash Flow
13.88 14.32 13.02 11.45
Other line items

Show all line items

Columns are period end dates